Clinical Trial Update: Evaluation of the Effect Foquest® on Sleep in Children Aged 6-12 With ADHD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of Foquest on sleep in children aged 6-12 with ADHD; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Fo quest (d-amphetamine? (Note: The document does not specify the generic name; Foquest is a brand name for guanfacine? )

Snippet

Sponsor: JPM van Stralen Medicine Professional | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: UNKNOWN